PAIGE HARVEY: Open Payments
NPI 1962017616 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 37 payments from 18 companies in 2025. Trend: 2023 $2,457 · 2024 $1,109 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $162 |
| Novo Nordisk Inc | 6 | $117 |
| PFIZER INC. | 3 | $76 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| GENZYME CORPORATION | 1 | $31 |
Products named: WATCHMAN FLX, Wegovy, VYNDAQEL, LifeVest, LEQVIO, ELIQUIS, JARDIANCE, AMVUTTRA.
Industry payments across MO — which companies pay providers there.
